Phase I Study to Assess Safety and Pharmacokinetics of GMI-1271 in Healthy Adult Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
In this study, the investigators will evaluate the safety, pharmacokinetics and effect on target biomarkers of coagulation, cell adhesion, and leukocyte and platelet activation of GMI-1271, an E-selectin antagonist, in healthy volunteers.
Epistemonikos ID: fc98e12966cfcb0be2dd0067d1291587f3f430b1
First added on: May 12, 2024